Literature DB >> 30390199

Response to "Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database".

Rashid Kazerooni1,2, Edward P Armstrong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30390199     DOI： 10.1007/s40261-018-0724-3

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  7 in total

1.  Drug-induced pancreatitis: lessons in data mining.

Authors:  Manfred Hauben; Lester Reich
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 2.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Decision support methods for the detection of adverse events in post-marketing data.

Authors:  M Hauben; A Bate
Journal:  Drug Discov Today       Date:  2009-01-31       Impact factor: 7.851

Review 4.  Quantitative signal detection using spontaneous ADR reporting.

Authors:  A Bate; S J W Evans
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

Review 5.  Data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Toshiyuki Sakaeda; Akiko Tamon; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

6.  Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database.

Authors:  Philippe Picaut
Journal:  Clin Drug Investig       Date:  2018-12       Impact factor: 2.859

Review 7.  Novel statistical tools for monitoring the safety of marketed drugs.

Authors:  J S Almenoff; E N Pattishall; T G Gibbs; W DuMouchel; S J W Evans; N Yuen
Journal:  Clin Pharmacol Ther       Date:  2007-05-30       Impact factor: 6.875
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.